Screener
Innoviva, Inc. INVA Giapreza — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Innoviva, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:26 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335235
| (In thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| GIAPREZA® | $22,299 | $17,329 | $42,530 | $35,602 |
| XACDURO® | 22,382 | 10,731 | 40,456 | 18,514 |
| XERAVA® | 6,739 | 7,094 | 9,367 | 11,317 |
| ZEVTERA® | 351 | 339 | 789 | 339 |
| Total net product sales | $51,771 | $35,493 | $93,142 | $65,772 |
Item 1. Financial Statements
FAQ
- What is Innoviva, Inc.'s giapreza — revenue?
- Innoviva, Inc. (INVA) reported giapreza — revenue of $22.3M in Q2 2026.
- How has Innoviva, Inc.'s giapreza — revenue changed year-over-year?
- Innoviva, Inc.'s giapreza — revenue increased by 28.7% year-over-year, from $17.33M to $22.3M.
- What is the long-term trend for Innoviva, Inc.'s giapreza — revenue?
- Over 2 years (2023 to 2025), Innoviva, Inc.'s giapreza — revenue has grown at a 33.5% compound annual growth rate (CAGR), from $41.29M to $73.61M.
- What does giapreza — revenue mean?
- This metric represents the total gross revenue generated from the sale of a specific product or service, excluding any sales-related taxes collected from customers. It serves as a primary indicator of the market demand and commercial performance for a specific segment within the company's portfolio.
Ask your AI about Innoviva, Inc.'s giapreza — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude